Key result
Adjuvant breast cancer therapies may result in treatment-related cardiotoxic outcomes in up to 33% of patients, highlighting the need for a multidisciplinary prospective surveillance system.
Population
Nonmetastatic breast cancer survivors, particularly postmenopausal women with cardiovascular disease risk…
Design
Review
Authors
Loading...
Supports cardiac monitoring in breast cancer survivors; leaves open optimal multidisciplinary surveillance protocols.
Highlights the significant risk of late-cardiac toxicity in breast cancer survivors and proposes a multidisciplinary prospective surveillance system for earlier detection and management.
Schmitz et al. (2012) conducted a review in Breast cancer. Multidisciplinary prospective surveillance system was evaluated. Adjuvant breast cancer therapies may result in treatment-related cardiotoxic outcomes in up to 33% of patients, highlighting the need for a multidisciplinary prospective surveillance system.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: